Products Cleared by FDA, now 510K approved
ANIARA CORPORATION GROWTH DRIVEN BY GLOBAL PRESENCE AND EXTENSIVE PRODUCT OFFERING FOR MEDICAL EXPLORATION AND DISCOVERY
Mason, OH – Aniara Corporation, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today’s highest standards for product quality and cost-efficient delivery.
Hyphen BioMed products now cleared by FDA (510K) and is now available for in vitro use exclusively from Aniara Corporation.
BioPhen Antithrombin 2.5 (Chromogenic)
BioPhen Antithrombin 5.0 (Chromogenic)
BioPhen Protein C 2.5 (Chromogenic)
BioPhen Protein C 5.0 (Chromogenic)
BioPhen Plasma Calibrator
BioPhen Plasma Control Normal
BioPhen Plasma Control Abnormal
BioPhen Heparin Calibrator
BioPhen UHF Calibrator
BioPhen LMWH Control Plasma
BioPhen LMWH Control Plasma Low
BioPhen UHF Control Plasma
Aniara introduces two new products to the market:
Chromogenic BioPhen Prothrombin assay
Chromogenic BioPhen Factor X assay
Aniara Corporation provides complete line of diagnostic and research reagents for thrombosis, hemostasis, and autoimmunity from Hyphen BioMed, that many are CE and 510K cleared. Kits are configured and/or customized to meet specific needs, while minimizing waste and prolonging shelf life. These products can be purchased at a significant discount through Aniara’s Research Value Program. Aniara offers bulk discount and custom made products.
Within that same product realm, Aniara Corporation sponsors an annual Coagulation Research Grant – $5,000.00 awarded to “established” investigators or “students/trainees” for a specialized project within the coagulation/hematology scientific field. Additionally, the Aniara CHTAE Committee selects a North American recipient, each year, to honor with the Coagulation/Hemostasis Technologist Award for Excellence. The honoree also receives a $1,000.00 check at the annual ASH meeting.
- Contact Information
- Jonas Kingo
- V.P of Aniara
- Aniara Corporation
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.